Who Paid My Doc
Elizabeth Bebin
Neurology with Special Qualifications in Child Neurology Birmingham, AL Medical Doctor
NPI 1437236882 CMS profile 574753
1717 6Th Ave S, Birmingham, AL 35233
General payments
$15,293
Research payments
$0
Ownership & investment interest
$0
Research they led as principal investigator
$3,713,329
Through program year 2023, Elizabeth Bebin of Birmingham, AL is reported in the CMS Open Payments database as having received $15,293 across 24 general payments and $0 in research payments paid to them. Separately, studies naming them as principal investigator received $3,713,329 in research payments, paid to institutions rather than to them.
No combined total General, research and ownership are kept apart. Each is reported under its own rules, and ownership is not money that moved at all but the value of a stake held. A meal, a clinical trial grant and a shareholding do not add up to anything meaningful, so this site does not add them. The principal-investigator line is research money paid to institutions for studies they led — not to them — and is not added to anything either.
General payments for this record sit in the 86th percentile of Neurology with Special Qualifications in Child Neurology profiles with reported payments. Percentile describes the distribution, not the conduct.
By program year
5 rows| Year | Kind | Relative to this record's peak year | Amount | Records |
|---|---|---|---|---|
| 2023 | General | $159 | 4 | |
| 2022 | General | $3,880 | 2 | |
| 2021 | General | $1,019 | 3 | |
| 2020 | General | $2,070 | 2 | |
| 2019 | General | $8,166 | 13 |
Beside peers
- Elizabeth Bebin
- Neurology with Special Qualifications in Child Neurology median
- Middle half of Neurology with Special Qualifications in Child Neurology
- National median
In program year 2025, general payments to Elizabeth Bebin were reported at $0. Among 1,228 Neurology with Special Qualifications in Child Neurology profiles paid that year, the median was $276 and the middle half received between $87 and $1,522.
Show as a table
| Year | Elizabeth Bebin | Neurology with Special Qualifications in Child Neurology median | Middle half | National median |
|---|---|---|---|---|
| 2019 | $8,166 | $262 | $68–$1,313 | $163 |
| 2020 | $2,070 | $188 | $46–$1,222 | $114 |
| 2021 | $1,019 | $183 | $45–$1,356 | $132 |
| 2022 | $3,880 | $229 | $72–$1,177 | $149 |
| 2023 | $159 | $269 | $93–$1,195 | $160 |
| 2024 | $0 | $300 | $98–$1,428 | $164 |
| 2025 | $0 | $276 | $87–$1,522 | $169 |
Breakdown
A payment can name more than one product, so these amounts overlap and do not add up to the general-payment figure.
Prescribing to Medicare patients
Part D · data year 2024 · 13 drugsPart D claims
203
Drug cost
$608,893
Branded share of claims
19.2%
| Drug | Type | Relative to their largest | Claims | Drug cost |
|---|---|---|---|---|
| Vigabatrin | Generic | 12 | $234,998 | |
| Afinitor Everolimus | Brand | 12 | $209,438 | |
| Epidiolex Cannabidiol (Cbd) | Brand | 16 | $69,135 | |
| Everolimus | Generic | 13 | $60,175 | |
| Sirolimus | Generic | 13 | $15,492 | |
| Fycompa Perampanel | Brand | 11 | $13,596 | |
| Divalproex Sodium | Generic | 20 | $4,017 | |
| Carbamazepine | Generic | 11 | $1,018 | |
| Lamotrigine | Generic | 24 | $486 | |
| Escitalopram Oxalate | Generic | 14 | $281 |
The 10 drugs with the highest cost, of 13 counted.
Drug cost is what was paid for the drugs at the pharmacy — by Medicare, the patient and others — and is not money to the prescriber. Medicare Part D only: drugs dispensed to Medicare beneficiaries. A drug with fewer than 11 claims for this prescriber is not published, so a missing drug does not mean zero. The medians are for the 13,695 Part D prescribers listed as Neurology; they describe a distribution and say nothing about conduct.
Records
24 reportedEvery payment, record by record
Date, company, amount, what it was for and the product named — filter by year, kind and company, or download as CSV.
Other Neurology with Special Qualifications in Child Neurology in Alabama
Alyssa Reddy
Neurology with Special Qualifications in Child Neurology · Birmingham, AL
Alan Percy
Neurology with Special Qualifications in Child Neurology · Birmingham, AL
Kimberly Limbo
Neurology with Special Qualifications in Child Neurology · Huntsville, AL
Michael Lopez
Neurology with Special Qualifications in Child Neurology · Birmingham, AL
Amitha Ananth
Neurology with Special Qualifications in Child Neurology · Birmingham, AL
Paul Maertens
Neurology with Special Qualifications in Child Neurology · Mobile, AL
Related records
Neurology with Special Qualifications in Child Neurology in Alabama
Practitioners in the same specialty and state, ranked by reported value.
All Neurology with Special Qualifications in Child Neurology
Everyone recorded under this specialty, nationwide.
Doctors in Alabama
Every practitioner in the state with a reported payment.
How to read this page
What each amount means, and what it does not mean.
What this means
U.S. law requires drug and medical device manufacturers to report payments and transfers of value they make to physicians and teaching hospitals. The Centers for Medicare & Medicaid Services publishes that record each year. This page shows what was reported about this person, and nothing else.
An ownership interest is different from the other two. It is not a payment: it is a stake — shares, options, a partnership holding — that a physician or an immediate family member held in a manufacturer during that year. The figure shown is what the stake was reported to be worth.
Research payments frequently pass through a clinician to the institution running a trial, and rarely represent personal income. They should be read differently from general payments.